97 related articles for article (PubMed ID: 24741906)
1. Non-interventional study AI463-12 of real-world chronic HBV infection management--baseline characteristics and treatment patterns of Polish patients kohort.
Simon K; Błudzin W; Dziambor A; Goryszewski D; Postawa-Kłosińska B; Sieklucki J; Kolasa K; Lescrauwaet B
Przegl Epidemiol; 2013; 67(4):617-21, 709-12. PubMed ID: 24741906
[TBL] [Abstract][Full Text] [Related]
2. Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.
Pellicelli AM; Barbaro G; Francavilla R; Romano M; Barbarini G; Mazzoni E; Mecenate F; Paffetti A; Barlattani A; Struglia C; Villani R; Nauri L; Nosotti L; Armignacco O; Ferri F; Camporiondo MP; Soccorsi F;
Clin Ther; 2008 Feb; 30(2):317-23. PubMed ID: 18343270
[TBL] [Abstract][Full Text] [Related]
3. [Factors associated with response to lamivudine: retrospective study of 233 patients with chronic hepatitis B].
Zhou HJ; Li SG; Wen FY; Yang XY; Wu JL; Tan B; Fu J
Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):564-8. PubMed ID: 19719911
[TBL] [Abstract][Full Text] [Related]
4. Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study.
Marcellin P; Arama V; Leblebicioglu H; Zarski JP; Zeuzem S; Mauss S; Sieklucki J; Acalovschi M; Usluer G; Klauck I; Morais E; Bjork S; Lescrauwaet B; Kamar D; Simon K;
Antivir Ther; 2014; 19(3):235-43. PubMed ID: 23574686
[TBL] [Abstract][Full Text] [Related]
5. Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients.
Buti M; Elefsiniotis I; Jardi R; Vargas V; Rodriguez-Frias F; Schapper M; Bonovas S; Esteban R
J Hepatol; 2007 Sep; 47(3):366-72. PubMed ID: 17561304
[TBL] [Abstract][Full Text] [Related]
6. Entecavir plus adefovir combination treatment for chronic hepatitis B patients after failure of nucleoside/nucleotide analogues.
Lim YS; Lee TH; Heo NY; Shim JH; Lee HC; Suh DJ
Antivir Ther; 2012; 17(1):53-60. PubMed ID: 22267469
[TBL] [Abstract][Full Text] [Related]
7. [Entecavir 1.0mg monotherapy or entecavir plus adefovir dipivoxil for patients with lamivudine-resistant chronic hepatitis B had suboptimal response to lamivudine plus adefovir dipivoxil].
Xing J; Han T; Liu L; Li Y; Li J; Li Y; Xiao SX
Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):828-32. PubMed ID: 22433304
[TBL] [Abstract][Full Text] [Related]
8. Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir.
Ong A; Wong VW; Wong GL; Chan HY; Tse CH; Chan HL
Aliment Pharmacol Ther; 2011 Oct; 34(8):972-81. PubMed ID: 21883327
[TBL] [Abstract][Full Text] [Related]
9. Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy.
Reijnders JG; Pas SD; Schutten M; de Man RA; Janssen HL
J Hepatol; 2009 Apr; 50(4):674-83. PubMed ID: 19231002
[TBL] [Abstract][Full Text] [Related]
10. [Lamivudine-resistant analysis and management for chronic hepatitis B patients with initial lamivudine therapy].
Xu H; Chen Y; He LL; Lei BJ; Lei XZ
Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):427-30. PubMed ID: 22053372
[TBL] [Abstract][Full Text] [Related]
11. Current trends in chronic hepatitis B management: results of a questionnaire.
Les I; García-Martínez R; Córdoba J; Quintana M; Esteban R; Buti M
Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1177-83. PubMed ID: 19430301
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.
Shim JH; Suh DJ; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
Hepatology; 2009 Oct; 50(4):1064-71. PubMed ID: 19637288
[TBL] [Abstract][Full Text] [Related]
13. Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study.
Lee SJ; Yim HJ; Hwang SG; Seo YS; Kim JH; Yoon EL; Lee JM; Kim BH; Park SJ; Park YM; Kim HS; Lee SH; Ahn SH; Lee JI; Lee JW; Kim IH; Kim HS; Hong SP
Scand J Gastroenterol; 2013 Feb; 48(2):196-204. PubMed ID: 23194375
[TBL] [Abstract][Full Text] [Related]
14. Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy.
Liang Y; Jiang J; Su M; Liu Z; Guo W; Huang X; Xie R; Ge S; Hu J; Jiang Z; Zhu M; Wong VW; Chan HL
Aliment Pharmacol Ther; 2011 Aug; 34(3):344-52. PubMed ID: 21671967
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies.
Arama V; Leblebicioglu H; Simon K; Zarski JP; Niederau C; Habersetzer F; Vermehren J; Bludzin W; Jinga M; Ulusoy S; Klauck I; Morais E; Bjork S; Lescrauwaet B; Kamar D; Zeuzem S;
Antivir Ther; 2014; 19(3):245-57. PubMed ID: 24343051
[TBL] [Abstract][Full Text] [Related]
16. Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir.
Heo NY; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Hepatol; 2010 Sep; 53(3):449-54. PubMed ID: 20646776
[TBL] [Abstract][Full Text] [Related]
17. Adding adefovir vs. switching to entecavir for lamivudine-resistant chronic hepatitis B (ACE study): a 2-year follow-up randomized controlled trial.
Yim HJ; Seo YS; Yoon EL; Kim CW; Lee CD; Park SH; Lee MS; Park CK; Chae HB; Kim MY; Baik SK; Kim YS; Kim JH; Lee JI; Lee JW; Hong SP; Um SH
Liver Int; 2013 Feb; 33(2):244-54. PubMed ID: 23295056
[TBL] [Abstract][Full Text] [Related]
18. Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance.
Yang HJ; Lee JH; Kim YJ; Yoon JH; Lee HS
J Med Virol; 2012 Mar; 84(3):424-30. PubMed ID: 22246827
[TBL] [Abstract][Full Text] [Related]
19. Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.
Reijnders JG; Deterding K; Petersen J; Zoulim F; Santantonio T; Buti M; van Bömmel F; Hansen BE; Wedemeyer H; Janssen HL;
J Hepatol; 2010 Apr; 52(4):493-500. PubMed ID: 20185191
[TBL] [Abstract][Full Text] [Related]
20. Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: a 4-year study.
Vassiliadis TG; Giouleme O; Koumerkeridis G; Koumaras H; Tziomalos K; Patsiaoura K; Grammatikos N; Mpoumponaris A; Gkisakis D; Theodoropoulos K; Panderi A; Katsinelos P; Eugenidis N
J Gastroenterol Hepatol; 2010 Jan; 25(1):54-60. PubMed ID: 19780875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]